ADIPOQ and Alzheimer disease: Taken together, the findings presented here reveal that adiponectin/ACRP30 attenuates GSK3β and NF-κB activation in the AD hippocampus, which likely contributes to the suppression of neuroinflammation and restoration of LTP.